期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

血管内皮生长因子在肾纤维化血管新生中的作用研究进展 被引量：1

下载PDF
导出
摘要 肾脏纤维化（renal interstitial fibrosis,RIF）是所有慢性肾脏疾病（chronic kidney disease,CKD）包括原发性、继发性肾小球疾病,肾小管、间质及血管疾病以及肾脏移植慢性排斥性病变发展至终末期肾脏病（end stage renal disease,ESRD）的最后共同通路。目前研究证明,肾脏纤维化与肾周血管损伤有关,肾周血管新生则可以延缓肾脏功能损害,
作者 钟建 李夏露
机构地区 广西中医药大学第一附属医院
出处 《广西中医药大学学报》 2013年第2期121-123,共3页 Journal of Guangxi University Of Chinese Medicine
基金 广西自然科学青年基金项目(2010GXNSFB013073)
关键词 VEGF 血管新生 肾纤维化 综述
分类号 R692 [医药卫生—泌尿科学]
  • 相关文献

参考文献23

  • 1Senger D R, GaUi S J, Dvorak A M, et al . Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid [J].Science,1983,219 (4587):983-985.
  • 2Houck K A, Ferrara N, Winer J, et al. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA[J]. Mol Endocrinol, 1991,5(12):1806-1814.
  • 3Poltorak Z, Cohen T, Sivan R, et al. VEGF145, a secreted vascular endothelial growth factor isoform that binds to ex- tracellular matrix [J]. J Biol Chem, 1997,272 (11):7151- 7158.
  • 4Mei J,Gao Y,Zhang L,et al. VEGF-siRNA silencing induces apoptosis, inhibits proliferation and suppresses vas-culogenic mimicry in osteosarcoma in vitro[J]. Exp Oncol, 2008,30:29-34.
  • 5Gerber H P, Hillan K J, Ryan A M, et al. VEGF is required forgrowth and urvival in neonatal mice [J]. Development, 1999, 126: 1149-1159.
  • 6Napoleone Ferrara. VEGF-A: a critical regulator of blood vessel growth [J ]. European Cytokine Network,2009,20 (4): 158-163.
  • 7代娜,李栋,时庆,汪大琨,付金秋,鞠秀丽.血管内皮生长因子对人骨髓和脐带间充质干细胞中内皮细胞组分的影响[J].中国实验血液学杂志,2012,20(3):717-721. 被引量：5
  • 8Bihon R L , Booker G W . The subtle side to hypoxia in- ducible factor (HIFalpha)regulation [J].Eur J Biochem, 2003,270(5 ) : 791-798.
  • 9Semenza G L.Hydroxylation of HIF-I: oxygen sensing at the molecular level[J]. Physiology(B ethesda), 2004, 19: 176-182.
  • 10Pugh C W,Patcliffe P J.Regulation of angiogenesis by hy- Poxia:role of the HIF system[J].Nat.Med,2003,9(6):677- 684.

二级参考文献44

  • 1黄学文,赵琪.碱性成纤维细胞生长因子（bFGF）mRNA的表达在部分恶性肿瘤中的检测[J].上海免疫学杂志,1996,16(6):350-352. 被引量：6
  • 2Jussila L, Alitalo K. Vascular growth factors and lymphangi - oegenesis[J], physiol Rev, 2002, 82(3) : 673 - 700.
  • 3Gabrilovich D, Chen H, Girgis K, et al. production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells[J]. Nature Med, 1996, 2:1096 - 1303,
  • 4Eppenberger U, Kueng W, Schlageppi Jm, et al. Markers of tum or angiogenesis and proteolysis independently define nigh and low risk subsets of node- negtive breast cancer- patients[J]. J clin Oncol, 1998, 16(9) :3129 - 3136.
  • 5TolM, Hoshimas, Takayanagi T, et al. Association of vascular endothelial growth factor expression with tumor angigenesis and with early replase in primary breast eanler[J]. Jpn J cancer Res, 1994, 85(60) : 1045 - 1050.
  • 6Ferrara N, Houck K, Jakeman L, et al. Molecular and biological properties of the vascular endothelial growth factor famialy of proteins[J]. Endocr Rev, 1992, 13;18 - 32.
  • 7Anthong J, Stuart J, Less F, et al. Vascular permeability factor expression and angiogenesis in patients with ductal carcinoma in situ of the breast cancer[J]. Canner, 1997, 80 : 1945 - 1953.
  • 8Deminkesen C, Buyukp inarbasili N, Ramazanoglu R, et al. The correlation of angiogenesis with meatastasis in primary cutaneous melanorna: a comparative analysis of microvessel density, expression of vascular endothehal growth factor and basic fibroblastic growth factor[J]. Pathology, 2006, 38(2) :132 - 137.
  • 9Rennko M, Quaro N, Morimoto T, et al. Nuclear and cytop - lasmic localiztion of different basic fibtoblast growth factor species [J]. J cell physial, 1990, 144:108 - 109.
  • 10Nanus DM, Schmitz - Drager BJ, Motzer RT, et al. Expression of basic fibtoblast growth factor in primary renal tumors corrslation with poor survival[J]. Nat Cancer Inst, 1993, 85:1 597 - 1 598.

共引文献5

同被引文献21

  • 1Kim NH,Jung HH,Cha DR,et al.Expression of vascular endothelial growth factor in response to high glucose in rat mesangial cells[J].J Endocrinol,2000,165(3):617-624.
  • 2Masabumi Shibuya.Vascular endothelial growth factor and its receptor system:physiological functions in angiogenesis and pathological roles in various diseases[J].J. Biochem,2013,153(1):13-19.
  • 3Johanna E.Lahteenvuo,MD;Markku T.Lahteenvuo,MD; antti Kivela,MD et al.Vaseular endothelial growth factor-B induces myocardium-specific angiogenesis and arteriogenesis via vascular endothelial growth factor receptor-I and neuropilin receptor-1 dependent mechanisms[J].Circulation,2009,119: 845-856.
  • 4Kendall RL,Wang G,Thomas KA.Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR[j]. Biochem Biophys Res Commun, 1996,226:324 -328.
  • 5Maynard SE,Min JY,Merchan J,et al.Excess placental soluble fms-like tyrosine kinase 1 (sFhl) may contribute to endothelial dysfunction, hypertension,and proteinuria in preeelampsia[J].J Clin Invest,2003,111: 649-658.
  • 6Michael L.Gagnon,Diane R.Bielenberg,Zeev Geehtman,et al. Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor: in vivo expression and antitumor activity[J]. 2000.97(6/:2573-2578.
  • 7Uniewicz KA,Cross MJ,Femig DG.Exogenous Recombinant Dimeric Neuropilin-1 Is Sufficient to Drive Angiogenesis[J].J Biol Chem, 2011,286(1):12-23.
  • 8Giovana S.Di Marco,Stefan Reuter,Uta Hillebrand,et al. The soluble VEGF receptor sFlt-1 contributes to endothelial dysfunction in CKD[J].J Am Soc Nephrol,2009,20(10):2235-2245,.
  • 9Hagmann H,Bossung V,Belaidi AA,et aLLow-molecular weight heparin increases circulating sFlt-I levels and enhances urinary elimination[J].PLoS One,2014,9(1).
  • 10Karalliedde J,Gnudi L.Endothelial factors and diabetic nephrooathy[J].Diabetes Care,2011,34(2):291-296.

引证文献1

二级引证文献1

广西中医药大学学报
2013年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部